Literature DB >> 29230670

Double somatic SMARCB1 and NF2 mutations in sporadic spinal schwannoma.

Irene Paganini1, Gabriele Lorenzo Capone1, Jeremie Vitte2, Roberta Sestini1, Anna Laura Putignano1, Marco Giovannini2, Laura Papi3.   

Abstract

In sporadic schwannomas, inactivation of both copies of the NF2 tumor suppressor gene on 22q is common. Constitutional mutations of SMARCB1 are responsible of schwannomatosis, an inherited tumor predisposition syndrome, characterized by the development of multiple schwannomas. We analysed the frequency of copy number changes on chromosome 22 and the mutation of NF2 and SMARCB1 in 26 sporadic schwannomas. We found two spinal schwannomas with an identical somatic missense mutation in SMARCB1 exon 9: p.(Arg377His). Both SMARCB1 mutated schwannomas had LOH of 22q and one of them harbored an inactivating mutation of NF2. The p.(Arg377His) change was not found in a series of 28 vestibular schwannomas. Our data indicate that mutations affecting SMARCB1 play a role in the development or progression of a small subset of spinal schwannomas and that biallelic inactivation of SMARCB1 may cooperate with deficiency of NF2 function in schwannoma tumorigenesis according to the "four-hit/three events" mechanism of tumorigenesis that we demonstrated in schwannomatosis-associated schwannomas.

Entities:  

Keywords:  NF2; Neurofibromatosis type 2; SMARCB1; Schwannomatosis

Mesh:

Substances:

Year:  2017        PMID: 29230670     DOI: 10.1007/s11060-017-2711-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  24 in total

1.  MutationTaster evaluates disease-causing potential of sequence alterations.

Authors:  Jana Marie Schwarz; Christian Rödelsperger; Markus Schuelke; Dominik Seelow
Journal:  Nat Methods       Date:  2010-08       Impact factor: 28.547

2.  Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations.

Authors:  N Sévenet; A Lellouch-Tubiana; D Schofield; K Hoang-Xuan; M Gessler; D Birnbaum; C Jeanpierre; A Jouvet; O Delattre
Journal:  Hum Mol Genet       Date:  1999-12       Impact factor: 6.150

3.  Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome.

Authors:  Yoshinori Tsurusaki; Nobuhiko Okamoto; Hirofumi Ohashi; Tomoki Kosho; Yoko Imai; Yumiko Hibi-Ko; Tadashi Kaname; Kenji Naritomi; Hiroshi Kawame; Keiko Wakui; Yoshimitsu Fukushima; Tomomi Homma; Mitsuhiro Kato; Yoko Hiraki; Takanori Yamagata; Shoji Yano; Seiji Mizuno; Satoru Sakazume; Takuma Ishii; Toshiro Nagai; Masaaki Shiina; Kazuhiro Ogata; Tohru Ohta; Norio Niikawa; Satoko Miyatake; Ippei Okada; Takeshi Mizuguchi; Hiroshi Doi; Hirotomo Saitsu; Noriko Miyake; Naomichi Matsumoto
Journal:  Nat Genet       Date:  2012-03-18       Impact factor: 38.330

4.  The mouse ortholog of the human SMARCB1 gene encodes two splice forms.

Authors:  C E Bruder; J P Dumanski; D Kedra
Journal:  Biochem Biophys Res Commun       Date:  1999-04-21       Impact factor: 3.575

Review 5.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

6.  Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers.

Authors:  N Sévenet; E Sheridan; D Amram; P Schneider; R Handgretinger; O Delattre
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

7.  SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.

Authors:  Piergiorgio Modena; Elena Lualdi; Federica Facchinetti; Lisa Galli; Manuel R Teixeira; Silvana Pilotti; Gabriella Sozzi
Journal:  Cancer Res       Date:  2005-05-15       Impact factor: 12.701

8.  Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors.

Authors:  Eric M Jackson; Angela J Sievert; Xiaowu Gai; Hakon Hakonarson; Alexander R Judkins; Laura Tooke; Juan Carlos Perin; Hongbo Xie; Tamim H Shaikh; Jaclyn A Biegel
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

9.  Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2.

Authors:  G A Rouleau; P Merel; M Lutchman; M Sanson; J Zucman; C Marineau; K Hoang-Xuan; S Demczuk; C Desmaze; B Plougastel
Journal:  Nature       Date:  1993-06-10       Impact factor: 49.962

10.  INI1 mutations in meningiomas at a potential hotspot in exon 9.

Authors:  U Schmitz; W Mueller; M Weber; N Sévenet; O Delattre; A von Deimling
Journal:  Br J Cancer       Date:  2001-01       Impact factor: 7.640

View more
  2 in total

1.  Hereditary intraspinal schwannomatosis with SMARCB1 gene mutation: A case report.

Authors:  Yu Li; Lulu Chen; Dongqi Shao; Binbin Zhang; Shan Xie; Xialin Zheng; Zhiquan Jiang
Journal:  J Clin Lab Anal       Date:  2022-04-21       Impact factor: 3.124

2.  Whole Genome Sequencing Identifies Key Genes in Spinal Schwannoma.

Authors:  Xin Gao; Li Zhang; Qi Jia; Liang Tang; Wen Guo; Tao Wang; Zheyu Wu; Wang Zhou; Zhenxi Li; Jianru Xiao
Journal:  Front Genet       Date:  2020-10-30       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.